Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Indazole-3-carboxamides and their use as WNT/B-catenin signaling pathway inhibitors

Indazole-3-carboxamides and their use as WNT/B-catenin signaling pathway inhibitors

US Patent 11066388 · Granted Jul 20, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of improving lung function2025
Methods of treating fibrosis2025
Isoquinolin-3-yl carboxamides and preparation and use thereof2025
Methods of treating fibrosis2025
Process for preparing N-(5-(3-(7-(3-fluorophenyl)-3H-imidazo[4,5-c]pyridin-2-yl)2024
Gamma-diketones for treatment and prevention of aging skin and wrinkles2023
Gamma-diketones for treatment and prevention of aging skin and wrinkles2023
Indazole-3-carboxamides and their use as Wnt/β-catenin signaling pathway inhibit2023
Indazole-3-carboxamides and their use as Wnt/β-catenin signaling pathway inhibit2023
5-heteroaryl substituted indazole-3-carboxamides and preparation and use thereof2023
Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereof2023
Indazole inhibitors of the Wnt signal pathway and therapeutic uses thereof2023